Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07208279

Cognitive Vitality Pilot Study

Effects of Dietary Supplement Intervention on Cognitive Function and Psychological Well-Being

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Arizona State University · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Accepted

Summary

This study's purpose is to evaluate the effects of a dietary supplement on cognitive function and psychological well-being in community-dwelling older adults aged 55+. The study involves taking a commercially available dietary supplement daily for 45 days. A 45-minute assessment will be conducted at the beginning and again at the end of the study.

Detailed description

The primary aim of this randomized, single-site pilot study is to evaluate the effects of the oral liquid dietary supplement Axolt (https://axoltbrain.com) on cognitive function in adults aged 55 and older without cognitive impairment, compared to a control group taking a commercially available, hydration powdered drink flavoring, Bolero (https://bolerousa.net) daily for 45 days. The secondary aim is to assess changes in mood and psychological well-being with supplement intake. The study will use validated, low-risk cognitive measures at baseline and at the end of the study to measure change over time. 20 individuals age 55 years and older will be recruited. Sample size for enrollment: (n =8) for the active group and (n=8) in the control group (16 total), accounting for an anticipated 20% drop out rate.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAxolt Brain Supplementhttps://axoltbrain.com/ Axolt is a brain health supplement. It includes native ingredients, formulated to help the brain perform at its best.
DIETARY_SUPPLEMENTBolero - Flavored Drink PlaceboThe control group will be asked to consume 1 packet of Bolero flavored water mix hydration enhancement also in about 16 oz of water once a day for 45 days.

Timeline

Start date
2025-09-01
Primary completion
2026-08-11
Completion
2026-08-11
First posted
2025-10-06
Last updated
2025-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07208279. Inclusion in this directory is not an endorsement.